We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Puerto Rico's unique combination of tax, financial and operational incentives continue to make it an attractive offshoring destination for U.S. drugmakers looking to rein in manufacturing costs.
Bayer Biological Products (Bayer BP) is employing innovative antitampering strategies as part of a companywide effort to combat product tampering and counterfeiting.
A growing number of pharmaceutical companies are beginning to outsource their manufacturing needs in order to focus more time and money on their drug pipelines.
Bayer Biological Products (Bayer BP) is employing innovative antitampering strategies as part of the company’s ongoing effort to combat product tampering and counterfeiting.
As radio-frequency identification (RFID) technology matures and becomes integral to the supply chain, many manufacturing executives are beginning to expect high returns from their investments in RFID systems.
While track-and-trace technologies such as bar coding are set to play a critical role not only in securing the pharmaceutical supply chain but also in preventing drug-dispensing mistakes, the FDA has failed to mandate that one critical element of the healthcare sector — hospitals — adopt the necessary technology.
Aventis Pharmaceuticals laid off 107 employees June 30 at is Kansas City, Mo., production facility, where the company manufactures allergy drug Allegra, diabetes drug Amaryl and antibiotic Ketek.
Unless the pharmaceutical industry takes steps to reduce the global price disparity for prescription drugs — including cutting prices in the U.S. — the importation of Rx drugs and price controls are inevitable, according to a new report from Ernst & Young.
A new FDA proposal that would require drug labeling to include a toll-free number for consumers to report drug side effects could cost the drug manufacturing industry more than $3 million to implement.